Late-onset Epilepsy and Cognition
迟发性癫痫和认知
基本信息
- 批准号:10401448
- 负责人:
- 金额:$ 19.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloidAmyloid beta-42Amyloid beta-ProteinAmyloid depositionApolipoproteinsAppointmentAtherosclerosis Risk in CommunitiesBiological MarkersBiometryClinicalClinical TrialsCodeCognitionCognitiveCohort StudiesDataDementiaDevelopmentDevelopment PlansDiagnosisEarly InterventionElderlyElectroencephalographyEpidemiologic MethodsEpidemiologyEpilepsyEtiologyFunctional disorderFundingFutureGenotypeGoalsGrantHourImpaired cognitionIncidenceIndividualInterventionKnowledgeLifeLightLongitudinal cohortManuscriptsMeasuresMentored Patient-Oriented Research Career Development AwardMentorsMonitorNatureNerve DegenerationNeurodegenerative DisordersNeurologistNeurologyOutcomes ResearchParticipantPathologicPathologyPatientsPersonsPhenotypePlasmaPopulationPublic Health SchoolsRecording of previous eventsResearchResearch PersonnelRiskSeizuresStrokeTestingTimeTrainingVisitWorkagedaggressive therapybrain magnetic resonance imagingcareer developmentcognitive changecognitive performancecognitive testingcohortinnovationmeetingsneurofilamentneuropathologyneurophysiologypreventprospectiverecruitresearch clinical testingskill acquisitionskillssupportive environmentsymposiumtau Proteinstau-1
项目摘要
PROJECT SUMMARY/ABSTRACT
Incident epilepsy is more common in the elderly than at any other time of life. While some cases are due to
stroke or known Alzheimer’s disease (AD), many cases have no known etiology. This proposal hypothesizes
that late-onset epilepsy (LOE; epilepsy starting at age 60 or later, in the absence of stroke or other identified
cause) is associated with cognitive decline and preexisting neuropathology such as amyloid deposition; i.e.,
LOE may be a marker for future cognitive impairment and dementia. The research will use data from the
ongoing longitudinal Atherosclerosis Risk in Communities (ARIC) cohort study (Aims 1 and 2), as well as from
a new cohort recruited as part of this grant (Aims 3 and 4). The specific aims are: 1) To test the hypothesis that
late-onset epilepsy (LOE) is associated with cognitive decline, and the subsequent development of MCI or
dementia. 2) To test whether Aβ 42/40 ratio is associated with LOE. 3) To determine whether individuals with
clinically-identified LOE have lower cognitive scores than individuals without LOE. 4) (Exploratory) To compare
AD biomarkers in patients with and without LOE, and correlate subclinical epileptiform activity with cognitive
performance in patients with LOE. Defining whether there is an association of LOE with an elevated risk of
future cognitive impairment could allow patients to have earlier interventions, which may help slow future
cognitive decline. This is an application for a Mentored Patient-Oriented Research Career Development Award
(K23). The overarching training goal of the proposed project is to provide the candidate with the skills
necessary to become an independent researcher in epilepsy related to aging. Specific training goals are to
obtain advanced training in epidemiology and biostatistics; to obtain training in recruiting and leading cohort
studies; to acquire and apply knowledge of AD pathophysiology and the use of biomarkers; to gain didactic and
experiential training in cognitive assessments in neurodegenerative diseases; and to advance professional
development skills in preparing manuscripts and presenting at conferences. The career development plan
includes classes in biostatistics and epidemiology at the Johns Hopkins School of Public Health; regular
meetings with mentors; seminars in biostatistics and the epidemiology of aging; seminars in AD
pathophysiology and research; and attending/presenting at national conferences. The candidate’s primary
appointment is in the Johns Hopkins Department of Neurology, an extremely supportive environment with a
strong history of junior investigators successfully transitioning to independent investigators.
项目总结/摘要
癫痫发作在老年人中比在生活中的任何其他时期都更常见。虽然有些案件是由于
中风或已知的阿尔茨海默病(AD),许多病例没有已知的病因。该提案假设
晚发性癫痫(LOE;癫痫开始于60岁或更晚,在没有中风或其他确定的
原因)与认知能力下降和先前存在的神经病理学(例如淀粉样蛋白沉积)有关;即,
LOE可能是未来认知障碍和痴呆的标志物。该研究将使用来自
正在进行的社区动脉粥样硬化风险(ARIC)队列研究(目标1和2),以及来自
作为该补助金的一部分,招募了一批新的人员(目标3和4)。具体目的是:1)检验假设,
晚发性癫痫(LOE)与认知能力下降相关,随后发生MCI或
痴呆2)检验Aβ 42/40比值是否与LOE相关。3)以确定是否有
临床鉴定的LOE的认知得分低于没有LOE的个体。4)(【探索性】)比较
伴和不伴LOE患者的AD生物标志物,以及亚临床癫痫样活动与认知功能的相关性
在LOE患者中的表现。定义LOE是否与以下风险升高相关:
未来的认知障碍可以让患者更早地进行干预,这可能有助于减缓未来的认知障碍。
认知能力下降这是一份申请指导病人为导向的研究职业发展奖
(K23)。拟议项目的总体培训目标是为候选人提供技能,
必须成为一个独立的研究人员在癫痫有关的老化。具体的培训目标是
获得流行病学和生物统计学方面的高级培训;获得招募和领导队列的培训
研究;获得和应用AD病理生理学知识和生物标志物的使用;获得教学和
神经退行性疾病认知评估的经验培训;并推进专业
发展准备稿件和在会议上发言的技能。职业发展计划
包括约翰霍普金斯公共卫生学院的生物统计学和流行病学课程;定期
与导师的会议;老龄化的生物统计学和流行病学研讨会; AD研讨会
病理生理学和研究;出席/出席国家会议。候选人的初选
任命是在约翰霍普金斯神经科,一个非常支持的环境,
初级调查员成功转型为独立调查员的良好历史。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emily Johnson其他文献
Emily Johnson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emily Johnson', 18)}}的其他基金
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 19.72万 - 项目类别:
Operating Grants